<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39340064</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Dynamic Vaccine Allocation for Control of Human-Transmissible Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1034</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12091034</ELocationID><Abstract><AbstractText>During pandemics, such as COVID-19, supplies of vaccines can be insufficient for meeting all needs, particularly when vaccines first become available. Our study develops a dynamic methodology for vaccine allocation, segmented by region, age, and timeframe, using a time-sensitive, age-structured compartmental model. Based on the objective of minimizing a weighted sum of deaths and cases, we used the Sequential Least Squares Quadratic Programming method to search for a locally optimal COVID-19 vaccine allocation for the United States, for the period from 16 December 2020 to 30 June 2021, where regions corresponded to the 50 states in the United States (U.S.). We also compared our solution to actual allocations of vaccines. From our model, we estimate that approximately 1.8 million cases and 9 thousand deaths could have been averted in the U.S. with an improved allocation. When case reduction is prioritized over death reduction, we found that young people (17 and younger) should receive priority over old people due to their potential to expose others. However, if death reduction is prioritized over case reduction, we found that more vaccines should be allocated to older people, due to their propensity for severe disease. While we have applied our methodology to COVID-19, our approach generalizes to other human-transmissible diseases, with potential application to future epidemics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Mingdong</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3724-5226</Identifier><AffiliationInfo><Affiliation>National Renewable Energy Laboratory, Mobility, Behavior, and Advanced Powertrains Department, Denver, CO 80401, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Thomas Lord Department of Computer Science, University of Southern California, Los Angeles, CA 90089, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kuofu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Epstein Department of Industrial and Systems Engineering, University of Southern California, Los Angeles, CA 90089, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Randolph</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7060-1272</Identifier><AffiliationInfo><Affiliation>Epstein Department of Industrial and Systems Engineering, University of Southern California, Los Angeles, CA 90089, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N/A</GrantID><Agency>University of Southern Califonira</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">transmission modeling</Keyword><Keyword MajorTopicYN="N">vaccine allocation</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340064</ArticleId><ArticleId IdType="pmc">PMC11435756</ArticleId><ArticleId IdType="doi">10.3390/vaccines12091034</ArticleId><ArticleId IdType="pii">vaccines12091034</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Self W.H., Tenforde M.W., Rhoads J.P., Gaglani M., Ginde A.A., Douin D.J., Olson S.M., Talbot H.K., Casey J.D., Mohr N.M., et al. Comparative effectiveness of Moderna, Pfizer-Biontech, and Janssen (Johnson &amp; Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions—united states, march–august 2021. Morb. Mortal. Wkly. Rep. 2021;70:1337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459899</ArticleId><ArticleId IdType="pubmed">34555004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauch C.T., Earn D.J.D. Vaccination and the Theory of Games. Proc. Natl. Acad. Sci. USA. 2004;101:13391–13394. doi: 10.1073/pnas.0403823101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0403823101</ArticleId><ArticleId IdType="pmc">PMC516577</ArticleId><ArticleId IdType="pubmed">15329411</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimit P.H.T., Monteiro L.H.A. A Vaccination Game Based on Public Health Actions and Personal Decisions. Ecol. Model. 2011;222:1651–1655. doi: 10.1016/j.ecolmodel.2011.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecolmodel.2011.02.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauch C.T. Imitation Dynamics Predict Vaccinating Behaviour. Proc. R. Soc. B Biol. Sci. 2005;272:1669–1675. doi: 10.1098/rspb.2005.3153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2005.3153</ArticleId><ArticleId IdType="pmc">PMC1560180</ArticleId><ArticleId IdType="pubmed">16087421</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu F., Rosenbloom D.I., Wang L., Nowak M.A. Imitation Dynamics of Vaccination Behaviour on Social Networks. Proc. R. Soc. B Biol. Sci. 2011;278:42–49. doi: 10.1098/rspb.2010.1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2010.1107</ArticleId><ArticleId IdType="pmc">PMC2992723</ArticleId><ArticleId IdType="pubmed">20667876</ArticleId></ArticleIdList></Reference><Reference><Citation>Klepac P., Megiddo I., Grenfell B.T., Laxminarayan R. Self-Enforcing Regional Vaccination Agreements. J. R. Soc. Interface. 2016;13:20150907. doi: 10.1098/rsif.2015.0907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2015.0907</ArticleId><ArticleId IdType="pmc">PMC4759795</ArticleId><ArticleId IdType="pubmed">26790996</ArticleId></ArticleIdList></Reference><Reference><Citation>Reluga T.C., Bauch C.T., Galvani A.P. Evolving Public Perceptions and Stability in Vaccine Uptake. Math. Biosci. 2006;204:185–198. doi: 10.1016/j.mbs.2006.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mbs.2006.08.015</ArticleId><ArticleId IdType="pubmed">17056073</ArticleId></ArticleIdList></Reference><Reference><Citation>Arefin M.R., Kabir K.M.A., Jusup M., Ito H., Tanimoto J. Social Efficiency Deficit Deciphers Social Dilemmas. Sci. Rep. 2020;10:16092. doi: 10.1038/s41598-020-72971-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72971-y</ArticleId><ArticleId IdType="pmc">PMC7527514</ArticleId><ArticleId IdType="pubmed">32999303</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M.E., Bowman C., Moghadas S.M., Summers R., Gumel A.B., Sahai B.M. A vaccination model for transmission dynamics of influenza. SIAM J. Appl. Dyn. Syst. 2004;3:503–524. doi: 10.1137/030600370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1137/030600370</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhankhar P., Nwankwo C., Pillsbury M., Lauschke A., Goveia M.G., Acosta C.J., Elbasha E.H. Public health impact and cost-effectiveness of hepatitis a vaccination in the United States: A disease transmission dynamic modeling approach. Value Health. 2015;18:358–367. doi: 10.1016/j.jval.2015.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2015.02.004</ArticleId><ArticleId IdType="pubmed">26091589</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai N., Song C., Xu R. Mathematical analysis and application of a cholera transmission model with waning vaccine-induced immunity. Nonlinear Anal. Real World Appl. 2021;58:103232. doi: 10.1016/j.nonrwa.2020.103232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nonrwa.2020.103232</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Zhang W., Nisar K.S., Gul N., Zeb A., Vijayakumar V. Dynamical aspects of a tuberculosis transmission model incorporating vaccination and time delay. Alex. Eng. J. 2023;66:287–300. doi: 10.1016/j.aej.2022.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aej.2022.11.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D.B.-C., Chang C.-J., Huang Y.-C., Wen Y.-W., Wu C.-L., Fann C.S.-J. Cost-effectiveness analysis of pneumococcal conjugate vaccine in taiwan: A transmission dynamic modeling approach. Value Health. 2012;15:15–19.</Citation><ArticleIdList><ArticleId IdType="pubmed">22265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko Y., Lee J., Kim Y., Kwon D., Jung E. COVID-19 vaccine priority strategy using a heterogenous transmission model based on maximum likelihood estimation in the Republic of Korea. Int. J. Environ. Res. Public Health. 2021;18:6469. doi: 10.3390/ijerph18126469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18126469</ArticleId><ArticleId IdType="pmc">PMC8296292</ArticleId><ArticleId IdType="pubmed">34203821</ArticleId></ArticleIdList></Reference><Reference><Citation>Monod M., Blenkinsop A., Xi X., Hebert D., Bershan S., Tietze S., Baguelin M., Bradley V.C., Chen Y., Coupland H., et al. Age groups that sustain resurging COVID-19 epidemics in the United States. Science. 2021;371:8372. doi: 10.1126/science.abe8372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe8372</ArticleId><ArticleId IdType="pmc">PMC8101272</ArticleId><ArticleId IdType="pubmed">33531384</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J., Cui J.-A., Zhou X. Dynamical behavior of a hepatitis b virus transmission model with vaccination. J. Theor. Biol. 2010;265:572–578. doi: 10.1016/j.jtbi.2010.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2010.05.038</ArticleId><ArticleId IdType="pubmed">20553944</ArticleId></ArticleIdList></Reference><Reference><Citation>Matrajt L., Longini I.M., Jr. Optimizing vaccine allocation at different points in time during an epidemic. PLoS ONE. 2010;5:13767. doi: 10.1371/journal.pone.0013767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013767</ArticleId><ArticleId IdType="pmc">PMC2978681</ArticleId><ArticleId IdType="pubmed">21085686</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubar K.M., Reinholt K., Kissler S.M., Lipsitch M., Cobey S., Grad Y.H., Larremore D.B. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science. 2021;371:916–921. doi: 10.1126/science.abe6959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe6959</ArticleId><ArticleId IdType="pmc">PMC7963218</ArticleId><ArticleId IdType="pubmed">33479118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A.N., Longini I.M., Jr. The critical vaccination fraction for heterogeneous epidemic models. Math. Biosci. 2003;181:85–106. doi: 10.1016/S0025-5564(02)00129-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-5564(02)00129-3</ArticleId><ArticleId IdType="pubmed">12421553</ArticleId></ArticleIdList></Reference><Reference><Citation>Duijzer L.E., van Jaarsveld W.L., Wallinga J., Dekker R. Dose-optimal vaccine allocation over multiple populations. Prod. Oper. Manag. 2018;27:143–159. doi: 10.1111/poms.12788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/poms.12788</ArticleId><ArticleId IdType="pmc">PMC7168135</ArticleId><ArticleId IdType="pubmed">32327917</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Lou Y. Optimizing COVID-19 vaccination programs during vaccine shortages. Infect. Dis. Model. 2022;7:286–298. doi: 10.1016/j.idm.2022.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2022.02.002</ArticleId><ArticleId IdType="pmc">PMC8872681</ArticleId><ArticleId IdType="pubmed">35233475</ArticleId></ArticleIdList></Reference><Reference><Citation>Duijzer E., van Jaarsveld W., Wallinga J., Dekker R. The most efficient critical vaccination coverage and its equivalence with maximizing the herd effect. Math. Biosci. 2016;282:68–81. doi: 10.1016/j.mbs.2016.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mbs.2016.09.017</ArticleId><ArticleId IdType="pubmed">27729237</ArticleId></ArticleIdList></Reference><Reference><Citation>Strohbehn G., Persad G., Parker W.F., Murthy S. Dose optimisation and scarce resource allocation: Two sides of the same coin. BMJ Open. 2022;12:063436. doi: 10.1136/bmjopen-2022-063436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-063436</ArticleId><ArticleId IdType="pmc">PMC9562718</ArticleId><ArticleId IdType="pubmed">36223969</ArticleId></ArticleIdList></Reference><Reference><Citation>Medlock J., Galvani A.P. Optimizing influenza vaccine distribution. Science. 2009;325:1705–1708. doi: 10.1126/science.1175570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1175570</ArticleId><ArticleId IdType="pubmed">19696313</ArticleId></ArticleIdList></Reference><Reference><Citation>Meehan M.T., Cocks D.G., Caldwell J.M., Trauer J.M., Adekunle A.I., Ragonnet R.R., McBryde E.S. Age-targeted dose allocation can halve COVID-19 vaccine requirements. medRxiv. 2020 doi: 10.1101/2020.10.08.20208108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.08.20208108</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Parra G., Cogollo M.R., Arenas A.J. Mathematical modeling to study optimal allocation of vaccines against COVID-19 using an age- structured population. Axioms. 2022;11:109. doi: 10.3390/axioms11030109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/axioms11030109</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertsimas D., Digalakis V., Jr., Jacquillat A., Li M.L., Previero A. Where to locate COVID-19 mass vaccination facilities? Nav. Res. Logist. (NRL) 2022;69:179–200. doi: 10.1002/nav.22007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nav.22007</ArticleId><ArticleId IdType="pmc">PMC8441649</ArticleId><ArticleId IdType="pubmed">38607841</ArticleId></ArticleIdList></Reference><Reference><Citation>Matrajt L., Eaton J., Leung T., Brown E.R. Vaccine optimization for COVID-19: Who to vaccinate first? Sci. Adv. 2021;7:1374. doi: 10.1126/sciadv.abf1374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abf1374</ArticleId><ArticleId IdType="pmc">PMC8128110</ArticleId><ArticleId IdType="pubmed">33536223</ArticleId></ArticleIdList></Reference><Reference><Citation>Valizadeh J., Boloukifar S., Soltani S., Hookerd E.J., Fouladi F., Rushchtc A.A., Du B., Shen J. Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic. Expert Syst. Appl. 2023;214:119009. doi: 10.1016/j.eswa.2022.119009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eswa.2022.119009</ArticleId><ArticleId IdType="pmc">PMC9598262</ArticleId><ArticleId IdType="pubmed">36312907</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer R., Kissane E., Madrigal A. The COVID tracking project. The Atlantic. Dec 10, 2020.</Citation></Reference><Reference><Citation>Mathieu E., Ritchie H., Rod´es-Guirao L., Appel C., Giattino C., Hasell J., Macdonald B., Dattani S., Beltekian D., Ortiz-Ospina E. Coronavirus Pandemic (COVID-19). Our World in Data. 2020.  [(accessed on 1 August 2022)].  Available online:  https://ourworldindata.org/coronavirus.</Citation></Reference><Reference><Citation>ASPA H. COVID-19 Vaccine Distribution Allocations by Jurisdiction-Pfizer. Centers for Disease Control and Prevention.  [(accessed on 1 August 2022)];2021  Available online:  https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/saz5-9hgg/about_data.</Citation></Reference><Reference><Citation>Lyu M., Hall R. Dynamic Modeling of Reported COVID-19 Cases and Deaths with Continuously Varying Case Fatality and Transmission Rate Functions. medRxiv. 2020.  [(accessed on 16 July 2024)].  Available online:  https://www.medrxiv.org/content/10.1101/2020.09.25.20201905v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.25.20201905v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu M., Liu K., Hall R.W. Spatial Interaction Analysis of Infectious Disease Import and Export between Regions. Int. J. Environ. Res. Public Health. 2024;21:643. doi: 10.3390/ijerph21050643.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph21050643</ArticleId><ArticleId IdType="pmc">PMC11120745</ArticleId><ArticleId IdType="pubmed">38791857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu M. Ph.D. Dissertation. University of Southern California; Los Angeles, CA, USA: 2023. Pandemic Prediction and Control with Integrated Dynamic Modeling of Disease Transmission and Healthcare Resource Optimization.</Citation></Reference><Reference><Citation>Gavin H.P. The Levenberg-Marquardt Algorithm for Nonlinear Least Squares Curve-Fitting Problems. Department of Civil and Environmental Engineering, Duke University; Durham, NC, USA: 2019. p. 19.</Citation></Reference><Reference><Citation>Fu Z., Liu G., Guo L. Sequential quadratic programming method for nonlinear least squares estimation and its application. Math. Probl. Eng. 2019;2019:3087949. doi: 10.1155/2019/3087949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/3087949</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>